Drug-labels.com

GLN-Posaconazole: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
100 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - GLN-Posaconazole

Serious Warnings and Precautions

  • Drug Interactions: Taking GLN-POSACONAZOLE with other medicines can cause serious side effects.

    Do NOT take GLN-POSACONAZOLE if you are taking any of the following:

    • ergot alkaloids, used to treat migraines
    • cisapride, used to treat stomach problems
    • pimozide, used to treat mental health problems
    • quinidine, used to treat irregular heartbeat
    • terfenadine and astemizole, used to treat allergies
    • certain statin medicines that lower cholesterol, such as atorvastatin, lovastatin, simvastatin
    • sirolimus, used in transplant patients

Avoid taking GLN-POSACONAZOLE with any of the following:

  • cimetidine, used to treat stomach problems
  • rifabutin, an antibiotic used to treat bacterial infections including tuberculosis
  • phenytoin, used to prevent seizures

If you are taking GLN-POSACONAZOLE with any of the following your healthcare professional may have to reduce your dose and monitor you closely:

  • cyclosporine or tacrolimus, used in transplant patients
  • vinca alkaloids, including vincristine, used to treat cancer
  • venetoclax, used to treat cancer
  • midazolam, used as a sedative to help you sleep
  • calcium channel blockers, used to treat high blood pressure
  • Heart Problems: GLN-POSACONAZOLE can cause serious heart problems including problems with your heart rhythm. Tell a healthcare professional immediately if you have any of the following symptoms while you are being treated with GLN-POSACONAZOLE:
  • very slow, fast or irregular heartbeat
  • shortness of breath
  • light-headedness
  • fainting
  • Liver Problems (including Liver Failure): GLN-POSACONAZOLE can cause serious liver problems including liver failure. Your healthcare professional will do blood tests to see how well your liver is working before you start treatment with GLN-POSACONAZOLE and while you are being treated. Tell a healthcare professional immediately if you have any of the following symptoms while you are being treated with GLN-POSACONAZOLE:

    • dark colored urine
    • pale stools
    • yellowing of the skin and eyes
    • abdominal pain
    • nausea and vomiting

What is GLN-POSACONAZOLE used for?

  • GLN-POSACONAZOLE delayed-release tablets are used:

    • to prevent fungal infections caused by the fungi Aspergillus and Candida in patients whose immune systems may be weakened due to other medicines or diseases.
    • to treat fungal infections caused by Aspergillus that have not improved during treatment with the anti-fungal medicines amphotericin B or itraconazole or in patients who cannot tolerate these medicines.
  • GLN-POSACONAZOLE delayed-release tablets can be used in patients 13 years of age and older.

How does GLN-POSACONAZOLE work?

GLN-POSACONAZOLE belongs to a group of medicines called triazole antifungal agents. GLN-POSACONAZOLE works by killing or stopping the growth of some types of fungi that can cause infections in humans.

What are the ingredients in GLN-POSACONAZOLE?

Medicinal ingredients: Posaconazole

Non-medicinal ingredients:

GLN-POSACONAZOLE Delayed-Release Tablets: Colloidal silicon dioxide, croscarmellose sodium, hydroxypropylcellulose, hypromellose acetate succinate, magnesium stearate, microcrystalline cellulose, talc, Opadry II Beige [consists of the following ingredients: iron oxide red, iron oxide yellow, Macrogol/PEG 3350 (polyethylene glycol 3350), polyvinyl alcohol partially hydrolyzed, titanium dioxide and talc]. The imprinting ink consist of ammonium hydroxide, ferrosoferric oxide, isopropyl alcohol, N-butyl alcohol, propylene glycol and shellac glaze.

Posaconazole comes in the following dosage forms:

GLN-POSACONAZOLE Delayed-Release Tablets: 100 mg

Do not use GLN-POSACONAZOLE if:

  • you are hypersensitive (allergic) to posaconazole or to any of the other ingredients in GLN-POSACONAZOLE (see What are the ingredients in GLN-POSACONAZOLE? section).
  • you are taking any of the following medicines:

    • ergot alkaloids, used to treat migraines
    • cisapride, used to treat stomach problems
    • pimozide, used to treat mental health problems
    • quinidine, used to treat irregular heartbeat
    • terfenadine and astemizole, used to treat allergies
    • certain statin medicines that lower cholesterol, such as atorvastatin, lovastatin, simvastatin
    • sirolimus, used in transplant patients

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take GLN-POSACONAZOLE. Talk about any health conditions or problems you may have, including if you:

  • have had an allergic reaction to other antifungal medicines such as ketoconazole, fluconazole, itraconazole or voriconazole.
  • are taking certain medicines that suppress your immune system such as cyclosporine and tacrolimus. Serious side effects that have been fatal, have happened in patients taking cyclosporine in combination with GLN-POSACONAZOLE. Your healthcare professional may adjust your dose of these immune suppressants and monitor their blood levels if you are taking them with GLN-POSACONAZOLE.
  • are taking certain medicines used to treat cancer such as venetoclax and vincristine. Toxicity from vincristine has happened in patients taking it in combination with GLN-POSACONAZOLE. This has caused serious side effects such as:

    • Damage to nervous tissue
    • Seizures
    • Numbness, pain and weakness in hand and feet due to damage to nerves
    • Muscles cramps, nausea, vomiting and confusion due to water retention in body
    • Blockage of the intestine (abdominal pain).
  • have or have had liver problems.

    have kidney problems.

  • have a history of heart problems, including heart failure, an irregular heartbeat, a slow heartbeat or a genetic condition called “congenital or acquired QT prolongation”.
  • have problems with your electrolytes (low levels of potassium, magnesium or calcium in your blood).
  • suffer from excessive vomiting or diarrhea.
  • are breastfeeding. Do not breastfeed while being treated with GLN-POSACONAZOLE unless you have discussed the risks and benefits with your healthcare professional.

  • are pregnant or planning on becoming pregnant. Do not use GLN-POSACONAZOLE during pregnancy unless you have discussed the risks and benefits with your healthcare professional. If you are a woman who could become pregnant, you must use effective birth control while you are being treated with GLN-POSACONAZOLE. Tell your healthcare professional immediately if you become pregnant while being treated with GLN-POSACONAZOLE.

Other warnings you should know about:

Blood tests: GLN-POSACONAZOLE can cause abnormal blood test results. Your healthcare professional may ask you to have blood tests while you are being treated with GLN-POSACONAZOLE.

Driving and using machines: Do not drive or operate machinery if you experience sleepiness or blurred vision.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines. The following medicines must not be taken with GLN-POSACONAZOLE:

  • cisapride, used to treat stomach problems
  • pimozide, used to treat mental health problems
  • quinidine, used to treat irregular heartbeat
  • ergot alkaloids, used to treat migraines
  • terfenadine and astemizole, used to treat allergies
  • certain statin medicines that lower cholesterol, such as atorvastatin, lovastatin, simvastatin
  • sirolimus, used in transplant patients

The following may interact with GLN-POSACONAZOLE:

  • rifabutin or rifampin, antibiotics used to treat bacterial infections like tuberculosis
  • phenytoin, used to prevent seizures
  • efavirenz, fosamprenavir, atazanavir and atazanavir/ritonavir, used to treat HIV infection
  • vinca alkaloids, including vincristine, used to treat cancer
  • venetoclax, used to treat cancer
  • cyclosporine and tacroliumus, used in transplant patients
  • midazolam, used as a sedative to help you sleep
  • statins, used to treat high cholesterol
  • calcium channel blockers, used to treat high blood pressure
  • digoxin, used to treat heart failure

How to take GLN-POSACONAZOLE:

  • GLN-POSACONAZOLE must only be used as directed by your healthcare professional.
  • Your healthcare professional will decide how long you are to be treated with GLN-POSACONAZOLE and your dose depending on your condition and how you respond to treatment.
  • Do not stop treatment early because your infection may not be fully cured. Even if you feel well, your immune system may still be weakened and you may still need treatment to prevent an infection.
  • Do not switch between GLN-Posaconazole delayed-release tablets, posaconazole oral suspension and Posaconazole solution for injection without talking to your healthcare professional. The dosing is different for each formulations.
  • Posaconazole delayed-release tablets can be taken with or without food.

  • Posaconazole delayed-release tablets must be swallowed whole. Use plenty of water if you have some difficulty swallowing.
  • Do not crush, chew, break, or dissolve the tablets.

Usual dose:

GLN-POSACONAZOLE Delayed-Release Tablets:

  • Take 300 mg (three 100 mg tablets) twice on the first day.
  • After the first day take 300 mg (three 100 mg tablets) once a day.

Overdose:

Take your bottle of GLN-POSACONAZOLE with you.

If you think you, or a person you are caring for, have taken too much GLN-POSACONAZOLE, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you miss taking a dose of GLN-POSACONAZOLE, take it as soon as possible. However, if it is almost time for the next dose, skip the missed dose and go back to the regular dosing schedule. Do not take a double dose to make up for the forgotten dose.

What are possible side effects from using GLN-POSACONAZOLE?

These are not all the possible side effects you may have when taking GLN-POSACONAZOLE. If you experience any side effects not listed here, tell your healthcare professional.

Side effects may include:

  • diarrhea
  • gas
  • nausea, vomiting
  • stomach pain
  • loss of appetite
  • abnormal taste in the mouth
  • dry mouth
  • swelling in the mouth
  • headache
  • dizziness
  • numbness or tingling
  • sleepiness, tiredness
  • weakness
  • rash
  • cough, shortness of breath

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
COMMON
Anemia (low red blood cells): shortness of breath, feeling very tired, pale skin,
  • ✓

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
fast heartbeat, loss of energy, or weakness.
Neutropenia (low white blood cells): infections (fever, chills, sore throat, mouth sores), weakness, fatigue, aches and pains, and flu-like symptoms.
  • ✓
Thrombocytopenia (low blood platelets): bruising or bleeding for longer than usual if you hurt yourself, fatigue and weakness, nosebleeds, tiny red spots on the skin.
  • ✓
Electrolyte imbalance (low levels of potassium, magnesium or calcium in your blood): weakness, fatigue, muscle cramps.
  • ✓
Edema: swelling of the hands or feet.
  • ✓
UNCOMMON
Heart problems: very slow, fast or irregular heartbeat, shortness of breath, light-headedness, fainting.
  • ✓
RARE
Allergic reaction: severe skin blistering, peeling, rash, swollen lips, mouth and throat, difficulty in breathing.
  • ✓
Liver problems (including liver failure): dark colored urine, pale stools, yellowing of the skin and eyes, abdominal pain, nausea, vomiting.
  • ✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health

Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage: Keep out of the reach and sight of children. Do not use this product after the expiry date stated on the label.

GLN-POSACONAZOLE Delayed-Release Tablets:

Store at room temperature (15°C to 30°C).

If you want more information about GLN-POSACONAZOLE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; or by contacting Glenmark Pharmaceuticals Canada Inc. at 1-844-801-7468.

Glenmark Pharmaceuticals Canada Inc.

1600 Steeles Ave. West

Suite 407, Concord, ON

L4K 4M2

Last Approved: October 3, 2023

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02542021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for GLN-Posaconazole

Rx or OTC
Prescription (Rx)?
DIN 02542021
Schedule(s) PRESCRIPTION
Active ingredient(s) Posaconazole 100 MG
Dosage form(s) Tablet (Delayed-Release)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J02 Antimycotics for systemic use
      1. J02A Antimycotics for systemic use
        1. J02AC Triazole derivatives, systemic antimycotics
          1. J02AC04 Posaconazole
Company GLENMARK PHARMACEUTICALS CANADA INC.
Current status Marketed
Current status date October 4, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.